AdrianaC.RossiMD

Hematology • New York, NY

Hematologic Oncology

Assistant Professor of Medicine

Join to view full profile

Dr. Rossi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rossi's full profile

Already have an account?

Office
Mount Sinai School Of Medicine Of New York University One Gustav
1 Gustave L Levy Pl
New York, NY 10029
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2010 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2007 - 2010
George Washington University School of Medicine and Health SciencesClass of 2007

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2010 - 2025
PA State Medical License 2007 - 2010

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

BiRd vs. Rd as Initial Therapy in Multiple Myeloma Start of enrollment: 2016 Feb 01
Terminated
Phase 3
Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M) Start of enrollment: 2018 Oct 23
Terminated
Phase 2
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma Start of enrollment: 2012 Mar 01
Active, not recruiting
Phase 2
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma Start of enrollment: 2021 Feb 24
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
Urvi A Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud...> ;Blood Advances. 2024 Jan 9
23 citations
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T Melnekoff, Yogita Ghodke-Puranik, Gunjan L Shah, Alexander Lesokhin, Serg...> ;Blood. 2023 Feb 16
16 citations
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience.
Taxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, David Siegel, Krina Patel, Sham Mailankody, Myo Htut, Nina Shah, Sandy W Wong, Surbhi Sidana, Andrew J Cowan, Melis...> ;Transplantation and Cellular Therapy. 2023 Apr 1
Editorial: T-cell directed therapies in multiple myeloma.
Joshua Richter, Larry D Anderson Jr, Karthik Ramasamy, Adriana Rossi> ;Frontiers in Oncology. 2023 Jan 1
1 citations
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Matthew J Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P Salvatore, Insara Jaffer-Sathick, Adriana C Rossi, Oscar Lahoud, Malin Hultcrantz, Urvi A Sha...> ;American Journal of Hematology. 2023 Mar 1
1 citations
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support.
Tarek H Mouhieddine, Erin Moshier, Santiago Thibaud, Benjamin Puliafito, Mohammad Rattu, Rita Jakubowski, Larysa Sanchez, Adriana Rossi, Cesar Rodriguez, Shambavi Rich...> ;Bone Marrow Transplantation. 2023 Jan 1
1 citations
Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review study.
Shebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, Shuchita Kaila, Kathleen Gray, Isabelle Ghelerter, Marie-Hélène Lafeuille, David Jayabalan, Patrick Lefebvre, Adr...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Aug 1
1 citations
Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart revi...
Shebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, Shuchita Kaila, Kathleen Gray, Isabelle Ghelerter, Marie-Hélène Lafeuille, Patrick Lefebvre, Adriana Rossi> ;BMC Cancer. 2021 Dec 2
10 citations
A Phase 1 Clinical Trial of Oral Eltanexor in Patients with Relapsed or Refractory Multiple Myeloma.
, , , , , , , , , , , , , , , , , , , , , , , , > ;American Journal of Hematology. 2021 Nov 24
19 citations
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, Natalie S. Callander, Muhamed Baljevic, Suzanne Lentzsch, Adriana C Rossi, Rami Kotb, Darrell White, Nizar J....> ;British Journal of Cancer. 2021 Nov 20
8 citations
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study.
Shebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, Shuchita Kaila, Kathleen Gray, Isabelle Ghelerter, Marie-Hélène Lafeuille, Patrick Lefebvre, Adriana Rossi> ;BMC Cancer. 2021 Nov 12
1 citations
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple mye...
Peter A. Forsberg, Adriana C Rossi, Angelique Boyer, Roger N. Pearse, Karen Pekle, David Jayabalan, Stephanie Lakritz, Kari Flicker, Drew Ribadeneyra, Brielle Liotta, ...> ;American Journal of Hematology. 2021 Sep 4
2 citations
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial.
Biran, N., Dhakal, B., Lentzsch, S., Siegel, D., Usmani, S., Rossi, A., Rosenbaum, C., Bhutani, D., Vesole, D., Rodriguez, C., Nooka, A., van Rhee, F., Stork-Sloots, L...> ;Ejhaem. 2021 Aug 1
1 citations
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma
Nina Orfali, Yuliya S. Jhanwar, Calvin Koo, Michelle Pasciolla, Maria Baldo, Edwidge Cuvilly, Richard R. Furman, Usama Gergis, June Greenberg, Danielle Guarneri, Jingm...> ;Leukemia & Lymphoma. 2021 Feb 13
1 citations
Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis
Marc Braunstein, Kseniya Petrova-Drus, David Jayabalan, Adriana C Rossi, Steven P. Salvatore, Karen L. Rech, Roger N. Pearse, Duane C. Hassane, John Postley, Yuliya Jh...> ;American Journal of Clinical Pathology. 2020 Nov 4
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi A Shah, Alexander M. Lesokhin, Hani H...> ;Blood Cancer Discovery. 2020 Nov 4
14 citations
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
Manish A. Shah, M. Frances Emlen, Tsiporah B. Shore, Sebastian Mayer, John P. Leonard, Adriana C Rossi, Peter Martin, Ellen K. Ritchie, Ruben Niesvizky, Raymond D. Pas...> ;CA. 2020 Sep 1
39 citations
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, Sydney X. Lu, Sham Mailankody, Urvi A Shah, Alexander M. Lesokhin, Hani H...> ;Blood Cancer Discovery. 2020 Jul 30
23 citations
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
, , , , , , , , , , , , , , , , , , , , , , , , , , > ;Medrxiv. 2020 Jun 11
17 citations
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
Alexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, Paul J. Christos, Usama Gergis, June Greenberg, Jingmei Hsu, Sebastian Mayer, Ruben Niesvizky, Roger N. Pears...> ;Bone Marrow Transplantation. 2019 Jun 12
4 citations
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
Peter A. Forsberg, Adriana C Rossi, Angelique Boyer, Linda Tegnestam, Roger N. Pearse, Arthur Perry, Karen Pekle, David Jayabalan, Scott Ely, Leora Boussi, Daniel W. S...> ;American Journal of Hematology. 2019 May 1
8 citations
Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC...
Jason Tay, Ravi Vij, Maxim Norkin, Francis K. Buadi, Tamila L. Kindwall-Keller, Jenna Roberts, Darrell White, Robert Wood, Sophee Blanthorn-Hazell, Adriana C Rossi, Su...> ;Leukemia & Lymphoma. 2019 Apr 16
12 citations
The impact of Daratumumab on transfusion service costs.
Melissa M. Cushing, Robert A. DeSimone, Ruchika Goel, Yen-Michael S. Hsu, Priscilla Parra, Sabrina E Racine-Brzostek, Diana Degtyaryova, Dian T. Lo, Meta Morrison, Kat...> ;Transfusion. 2019 Apr 1
10 citations
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.
Tomer M Mark, Peter A. Forsberg, Adriana C Rossi, Roger N. Pearse, Karen Pekle, Arthur Perry, Angelique Boyer, Linda Tegnestam, David Jayabalan, Morton Coleman, Ruben ...> ;Blood Advances. 2019 Feb 26
21 citations
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
Koen van Besien, Lizamarie Bachier-Rodriguez, Michael J. Satlin, Maxwell A. Brown, Usama Gergis, Danielle Guarneri, Jingmei Hsu, Adrienne A. Phillips, Sebastian Mayer,...> ;Leukemia & Lymphoma. 2019 Feb 10
Join now to see all

Abstracts/Posters

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Multiple Myeloma Not ...
Adriana C. Rossi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

$First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma$
First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple MyelomaNovember 20th, 2019
Treating Multiple Myeloma: Common Side Effects to Watch Out ForJuly 1st, 2019
Treating Multiple Myeloma: Questions to Ask Your DoctorJune 26th, 2019
Join now to see all